Jiangsu Aoyang Health Industry Co.ltd. (SHE:002172)
China · Delayed Price · Currency is CNY 3.150
-0.030 (-0.94%)
Jun 10, 2026, 3:04 PM CST
SHE:002172 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 28.03 | 41.29 | 40.56 | 49.68 | -15.37 | -1,039 |
Depreciation & Amortization | 59.64 | 59.64 | 67.37 | 72.43 | 76.23 | 221.21 |
Other Amortization | 4.17 | 4.17 | 1.9 | 2.76 | 4.8 | 5.48 |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | 0.06 | -0.03 | 0.01 | -8.8 |
Asset Writedown & Restructuring Costs | 2.76 | 2.76 | 0.14 | 1 | 0.05 | 745.14 |
Loss (Gain) From Sale of Investments | -1.85 | -1.85 | 1.31 | -20.77 | 22.2 | 3.98 |
Provision & Write-off of Bad Debts | 15.34 | 15.34 | 3.51 | 2.86 | -45.12 | 52.35 |
Other Operating Activities | 253.79 | 28.75 | 39.19 | 40.33 | 92.22 | 114.74 |
Change in Accounts Receivable | -520.64 | -520.64 | 9.14 | 118.06 | 224.05 | 982.66 |
Change in Inventory | 15.79 | 15.79 | 33.94 | -7.77 | 5.99 | 93.76 |
Change in Accounts Payable | 369.14 | 369.14 | -196.05 | -203.71 | -396.23 | -1,204 |
Operating Cash Flow | 224.4 | 12.62 | 0.44 | 54.3 | -33.8 | -33.47 |
Operating Cash Flow Growth | 590.16% | 2777.11% | -99.19% | - | - | - |
Capital Expenditures | -21.25 | -32.58 | -28.64 | -63.59 | -193.17 | -221.12 |
Sale of Property, Plant & Equipment | 0.19 | 0.25 | 0.03 | 0.11 | 1,031 | 495.65 |
Divestitures | - | - | - | 24.41 | 25.6 | - |
Investment in Securities | -0.3 | -0.3 | -10.2 | -4.76 | 32.89 | - |
Other Investing Activities | -10.76 | -10.76 | - | - | - | - |
Investing Cash Flow | -32.13 | -43.39 | -38.81 | -43.84 | 896.52 | 274.54 |
Long-Term Debt Issued | - | 1,196 | 1,296 | 1,571 | 1,634 | 2,785 |
Long-Term Debt Repaid | - | -1,262 | -1,264 | -1,674 | -2,324 | -3,192 |
Net Debt Issued (Repaid) | -131.36 | -66.17 | 31.34 | -103.54 | -690.53 | -407.13 |
Common Dividends Paid | -30.81 | -28.49 | -32.65 | -34.56 | -48.22 | -110.03 |
Other Financing Activities | -142.48 | 19.3 | -48.24 | 126.68 | 98.43 | -55.04 |
Financing Cash Flow | -304.65 | -75.36 | -49.55 | -11.43 | -640.33 | -572.19 |
Foreign Exchange Rate Adjustments | -0.04 | -0.02 | 0.01 | 0.02 | 0.07 | -0.03 |
Net Cash Flow | -112.41 | -106.15 | -87.9 | -0.94 | 222.46 | -331.15 |
Free Cash Flow | 203.14 | -19.96 | -28.2 | -9.29 | -226.97 | -254.58 |
Free Cash Flow Growth | 28128.96% | - | - | - | - | - |
Free Cash Flow Margin | 11.53% | -1.10% | -1.40% | -0.43% | -11.23% | -17.81% |
Free Cash Flow Per Share | 0.28 | -0.02 | -0.04 | -0.01 | -0.29 | -0.33 |
Cash Income Tax Paid | 42.11 | 50.76 | 54.51 | 45.82 | 23.53 | 39.1 |
Levered Free Cash Flow | 16.07 | -34.41 | 64.33 | 0.48 | 443.68 | -1,506 |
Unlevered Free Cash Flow | 35.25 | -15.24 | 91.41 | 27.47 | 482.78 | -1,420 |
Change in Working Capital | -137.47 | -137.47 | -153.62 | -93.97 | -168.83 | -128.65 |